Wednesday, September 05, 2018

Kiadis Pharma not for Graham Defensive Investor

Revenue = 0 EUR

Book value = EUR 25m Equity / 20,1m shares = EUR 1 per share

Current share price: EUR 12,20

Price of private placement March 2018 (sale of shares to raise money for company) EUR 9,-

The company is developing something which could benefit the health of a lot of people and earn money for investors. How much that could be per share is outside my "circle of competence"

Do you speak Dutch? If so please opt-in at Thanks in advance! Comments, questions or E-mails welcome:

No comments: